It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
In a series of articles this month, The Washington Free Beacon’s Aaron Sibarium reported that hospitals in Minnesota, Utah, New York, Illinois, Missouri, and Wisconsin have been using race as a factor in which COVID-19 patients receive scarce monoclonal-antibody treatments first. Last year, SSM Health, a network of 23 hospitals, began using a points system to ration access to Regeneron. The drug would be given to patients only if they netted 20 points or higher. Being “non-White or Hispanic” counted for seven points, while obesity got you only one point—even though, according to the CDC, “obesity may triple the risk of hospitalization due to a COVID-19 infection.” Based on this scoring system, a 40-year-old Hispanic male in perfect health would receive priority over an obese, diabetic 40-year-old white woman with asthma and hypertension.
Meanwhile, Minnesota’s Department of Health used a scoring calculator that counted “BIPOC status” as equivalent to being 65 years and older in its risk assessment. (BIPOC is shorthand for Black, Indigenous, and people of color.) New York did away with a points system entirely; people of color are automatically deemed to be at elevated risk of harm from COVID—and therefore are given higher priority for therapeutics—irrespective of their underlying health conditions.
Most common blood type by ethnicity
In the U.S., 38% of the population have O-positive blood, making it the most common blood type.
According to the American Red Cross, the following statistics show the most common blood types in the U.S.:
African American: 47% O-positive, 24% A-positive, and 18% B-positive
Latin American: 53% O-positive, 29% A-positive, and 9% B-positive
Asian: 39% O-positive, 27% A-positive, and 25% B-positive
Caucasian: 37% O-positive, 33% A-positive, and 9% B-positive
The O- blood group had a 2.1% chance of getting SARS-CoV-2 infection (95% CI, 1.8-2.3%), the lowest unadjusted probability of all blood groups. The aRR for SARS-CoV-2 infection in the O blood group was 0.88 (95% CI, 0.84-0.92) vs all other blood groups, and the ARD was -3.9 per 1,000 (95% CI, -5.4 to -2.5). Comparatively, the highest unadjusted probability of SARS-CoV-2 infection was in the B+ blood group (4.2%; 95% CI, 4.0-4.5%). Results also indicated the aRR for SARS-CoV-2 infection was higher in patients with AB blood type compared with type A.
Rh- status seemed protective against SARS-CoV-2 infection with an aRR of 0.79 (95% CI, 0.73-0.85) and an ARD of -6.8 per 1,000 (95% CI, -8.9 to -4.7). The O- blood group also seemed protective, with an aRR of 0.74 (95% CI, 0.66-0.83) and an ARD of -8.2 per 1,000 (95% CI, -10.8 to -5.3). The relative protective effects of O, Rh-, and O- blood groups were greatest in patients younger than age 70.
originally posted by: TonyS
a reply to: loveguy
Uh, did I read that correctly, the group least likely to contract the disease is the group prioritized to recieve treatment?
originally posted by: ketsuko
a reply to: noscopebacon
Then why give someone extra points gor their racial background? I hate to tell you this but it very much is rooted in the idea of equity and race. If I were not phone posting I would look it up, the reason rests on being part of historically disadvantaged groups.
originally posted by: noscopebacon
a reply to: TonyS
its called reality
they arent going to give a limited supply of life saving drugs on someone that it isnt going to help.
its basic triage
its not race based its just outcome based.
if the fact is that some races are unhealthier than others or have other comorbidities that isn't the doctors fault.
they are there to save lives not waste valuable and unrefillable resources on people that will die anyway.
originally posted by: loveguy
originally posted by: TonyS
a reply to: loveguy
Uh, did I read that correctly, the group least likely to contract the disease is the group prioritized to recieve treatment?
Bingo!
bloodclots
The jab targets the ability to fend off infection....
Bloodclots was one of the first diseases people came down with after the jab.
a factor in which COVID-19 patients receive scarce monoclonal-antibody treatments first.